Brief: ScPharmaceuticals Announces FDA Approval Of Supplemental New Drug Application Expanding The Furoscix Indication In Heart Failure

Scpharmaceuticals

12/08/2024 11:27

Aug 12 (Reuters) - scPharmaceuticals Inc  SCPH.O :
    * SCPHARMACEUTICALS ANNOUNCES FDA APPROVAL OF SUPPLEMENTAL
NEW
DRUG APPLICATION EXPANDING THE FUROSCIX INDICATION IN HEART
FAILURE

Source text for Eikon:  ID:nGNX7yjLmp 
Further company coverage:  SCPH.O 

 (Reuters.Briefs@thomsonreuters.com)